Cytosorbents (CTSO) Prelim. Q3 Revenue Misses Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Cytosorbents (CTSO) Prelim. Q3 Revenue Misses Consensus

CytoSorbents (CTSO) PT Lowered to $10 at Cowen, Keeps 'Outperform'

October 13, 2021 5:50 AM EDT

Cowen analyst Joshua Jennings lowered the price target on CytoSorbents (NASDAQ: CTSO) to $10.00 (from $14.00) while maintaining an Outperform rating following results and FDA approval of the IDE for DrugSorb's U.S. trial.

The analyst commented, "CTSO reported preliminary 3Q revenue of $9.7M,... More